Non-Partisan Watchdog Group Files FDA Petition to Better Protect Drug Trial Participants

Unreliable Drug Testing Practices Put Clinical Trial Participants and Consumers At Risk, Contends the Center for Responsible Science

Los Angeles, Calif., July 17, 2014--The Center for Responsible Science (CRS), a non-partisan, nonprofit watchdog group advocating for more modern and accurately predictive test methods for new drug development, is warning the public that conventional drug testing may put the health of clinical trial participants and consumers at risk. CRS has filed a citizen petition with the Food and Drug Administration (FDA) to update its informed consent regulations so that clinical trial participants will no longer be kept in the dark about the hazards they may unwittingly assume when they agree to participate.